ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,531, issued on Feb. 17, was assigned to INNOVENT BIOLOGICS (SUZHOU) Co. LTD. (Jiangsu, China).

"Interleukin-2 and use thereof" was invented by Lishan Kang (Jiangsu, China), Fenggen Fu (Jiangsu, China), Shuaixiang Zhou (Jiangsu, China), Xinzhen Shi (Jiangsu, China) and Junjian Liu (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel interleukin-2 (IL-2) mutant protein. The present invention further provides a fusion protein and an immunoconjugate comprising the IL-2 mutant protein, a nucleic acid encoding the IL-2 mutant protein, and a vector and a host cell comprising the nucleic acid. The present i...